Weight Loss Drugs

Ozempic Semaglutide GLP-1 Agonists Wegovy Tirzepatide Clinical Trials GLP-1 Receptor Agonists Side Effects Novo Nordisk Zepbound GLP-1 Drugs Ozempic and Wegovy Amycretin Heart Attack Prevention FDA Approval Chronic Weight Management Safety Concerns Market Growth Supply Issues Weight Regain Study Results Market Impact Popularity GLP-1 Agonist Drugs GLP1s Drug Efficacy GLP-1 Medications Viking Therapeutics Diabetes Treatment Amgen Oral Medications Danuglipron Competition Type 2 Diabetes Copycat Medications Semaglutides Counterfeit Products GLP-1 Addiction Treatment Regulation Eli Lilly

3 ARTICLES

12 hours ago

Ekta Kapoor's Instagram Post Fuels Speculation About Ram Kapoor's Weight Loss Claims

The television producer's remarks referencing weight loss methods and her hit show 'Bade Achhe Lagte Hain' spark theories of a veiled jab at the actor's transformation.

Stories older than 24h

3 ARTICLES

2 weeks ago

Al Roker Supports Use of Weight Loss Drugs, Citing Unique Challenges of Food Addiction

4 ARTICLES

4 months ago

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

3 ARTICLES

4 months ago

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

4 ARTICLES

4 months ago

UK Regulators Warn Against Misuse of Weight-Loss Injections

11 ARTICLES

4 months ago

Bank of Canada Expected to Announce Significant Rate Cut

4 ARTICLES

5 months ago

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

10 ARTICLES

5 months ago

CDC Reports Stagnation in U.S. Obesity Rates, but Severe Obesity Continues to Rise

7 ARTICLES

5 months ago

23andMe Board Resigns Amid CEO's Privatization Push

3 ARTICLES

6 months ago

Weight Loss Drugs Significantly Reduce COVID-19 Mortality

19 ARTICLES

6 months ago

Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

33 ARTICLES

6 months ago

Eli Lilly Introduces Affordable Zepbound Vials to Address Obesity Drug Shortage

6 ARTICLES

6 months ago

New Study Fuels Debate on Semaglutide's Mental Health Risks

4 ARTICLES

7 months ago

Illegal Online Pharmacies Selling Dangerous Weight Loss Drugs

4 ARTICLES

7 months ago

Weight-Loss Drugs Reshape Health and Consumer Markets

10 ARTICLES

7 months ago

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

4 ARTICLES

7 months ago

Ozempic Shows Promise Beyond Diabetes Treatment

18 ARTICLES

8 months ago

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

6 ARTICLES

9 months ago

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%

3 ARTICLES

last year

Eli Lilly's Tirzepatide Shows Promising Results in MASH Treatment, Fuels Revenue Growth

10 ARTICLES

last year

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition

3 ARTICLES

last year

Eli Lilly Surpasses Tesla in Market Cap Amid EV Maker's Stock Plunge

9 ARTICLES

last year

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies

27 ARTICLES

last year

Novo Nordisk's Wegovy shows promise in cutting cardiovascular risk but faces supply shortages and insurance coverage challenges

Particle.news

Weight Loss Drugs

Ekta Kapoor's Instagram Post Fuels Speculation About Ram Kapoor's Weight Loss Claims

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

U.S. Obesity Rates Decline for First Time in Over a Decade

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Al Roker Supports Use of Weight Loss Drugs, Citing Unique Challenges of Food Addiction

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

UK Regulators Warn Against Misuse of Weight-Loss Injections

Never miss stories about

Weight Loss Drugs

Bank of Canada Expected to Announce Significant Rate Cut

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

CDC Reports Stagnation in U.S. Obesity Rates, but Severe Obesity Continues to Rise

23andMe Board Resigns Amid CEO's Privatization Push

Weight Loss Drugs Significantly Reduce COVID-19 Mortality

Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

Eli Lilly Introduces Affordable Zepbound Vials to Address Obesity Drug Shortage

New Study Fuels Debate on Semaglutide's Mental Health Risks

Illegal Online Pharmacies Selling Dangerous Weight Loss Drugs

Weight-Loss Drugs Reshape Health and Consumer Markets

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

Ozempic Shows Promise Beyond Diabetes Treatment

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%

Eli Lilly's Tirzepatide Shows Promising Results in MASH Treatment, Fuels Revenue Growth

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition

Eli Lilly Surpasses Tesla in Market Cap Amid EV Maker's Stock Plunge

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies

Novo Nordisk's Wegovy shows promise in cutting cardiovascular risk but faces supply shortages and insurance coverage challenges

Never miss stories about

Weight Loss Drugs